How are the genetic profiles of acute myeloid leukemia (AML) and the myelodysplastic syndromes (MDS) similar, and how do these two disorders differ? These are complex questions – and difficult ones to answer intelligently right now, chiefly because so little is currently understood about the
No takes yet. Share an insight, caveat, or question.
David P. Steensma (2007) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: